1. Brain metastasis in breast cancer: a comprehensive literature review

   • Rezvan Rostami
   • Shivam Mittal
   • Bahman Jabbari

   Topic Review 24 February 2016 Pages: 407 - 414

   

2. Positron emission tomography of high-grade gliomas

   • Guido Frosina

   Topic Review 20 February 2016 Pages: 415 - 425

   

3. The challenges associated with molecular targeted therapies for glioblastoma

   • Toni Rose Jue
   • Kerrie L. McDonald

   Topic Review 22 February 2016 Pages: 427 - 434

4. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system

   • Johannes van de Nes
   • Marco Gessi
   • Klaus G. Griewank

   Laboratory Investigation 07 January 2016 Pages: 435 - 444

   

5. The effects of antiepileptic drugs on the growth of glioblastoma cell lines

   • Ching-Yi Lee
   • Hung-Yi Lai
   • Shih-Tseng Lee

   Laboratory Investigation Open access 13 January 2016 Pages: 445 - 453

   

6. Long-term exposure to irinotecan reduces cell migration in glioma cells

   • A. B. Al-Ghafari
   • W. Punjaruk
   • I. D. Kerr

   Laboratory Investigation 30 January 2016 Pages: 455 - 462

   

7. Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy

   • James R. Hands
   • Graeme Clemens
   • Matthew J. Baker

   Laboratory Investigation Open access 13 February 2016 Pages: 463 - 472

   

8. In vivo multiphoton tomography and fluorescence lifetime imaging of human brain tumor tissue

   • Sven R. Kantelhardt
   • Darius Kalasauskas
   • Alf Giese

   Laboratory Investigation 30 January 2016 Pages: 473 - 482

   

9. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma

   • Soma Ghasimi
   • Carl Wibom
   • Beatrice Melin

   Laboratory Investigation Open access 02 February 2016 Pages: 483 - 492

   

10. The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?

    • D. T. Blumenthal
    • L. Mendel
    • F. Bokstein

    Clinical Study 31 December 2015 Pages: 493 - 502

    

11. Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?

    • D. T. Blumenthal
    • L. Mendel
    • F. Bokstein

    Erratum 08 March 2016 Pages: 503 - 503

12. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide

    • Navid Redjal
    • Clemens Reinshagen
    • Brian V. Nahed

    Clinical Study 01 February 2016 Pages: 505 - 514

    

13. Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI

    • Moran Artzi
    • Gilad Liberman
    • Dafna Ben Bashat

    Clinical Study 11 January 2016 Pages: 515 - 524

    

14. Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer

    • Ren Yuan
    • Andrew Yamada
    • Cheryl Ho

    Clinical Study 16 January 2016 Pages: 525 - 533

    

15. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

    • Wenyin Shi
    • Joshua D. Palmer
    • Yaacov R. Lawrence

    Clinical Study 29 January 2016 Pages: 535 - 539

    

16. The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area

    • Jaejoon Lim
    • Kyunggi Cho

    Clinical Study Open access 17 February 2016 Pages: 541 - 550

    

17. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery

    • Amir Zolal
    • Tareq A. Juratli
    • Dietmar Krex

    Clinical Study 30 January 2016 Pages: 551 - 557

    

18. Cognitive screening in patients with intracranial tumors: validation of the BCSE

    • Juliane Becker
    • Elisabeth Steinmann
    • Simone Goebel

    Clinical Study 01 February 2016 Pages: 559 - 567

19. Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial

    • Carmen Balana
    • Ramon De Las Penas
    • Salvador Villà

    Clinical Study 03 February 2016 Pages: 569 - 579

    

20. Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?

    • Sebastian Adeberg
    • Christian Diehl
    • Jürgen Debus

    Clinical Study 30 January 2016 Pages: 581 - 587

    

21. “Comet tail sign”: A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors

    • Koichi Mitsuya
    • Yoko Nakasu
    • Masahiro Endo

    Clinical Study Open access 02 February 2016 Pages: 589 - 595

    

22. Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients

    • Mostafa Farzin
    • Michael Molls
    • Christoph Straube

    Clinical Study 06 February 2016 Pages: 597 - 606

    

23. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases

    • Amparo Wolf
    • Sayyad Zia
    • Douglas Kondziolka

    Clinical Study 06 February 2016 Pages: 607 - 615

    

24. Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach

    • Giordano Savelli
    • Mirco Bartolomei
    • Mario Bignardi

    Letter to the Editor 02 February 2016 Pages: 617 - 619